A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects with Moderately to Severely Active Ulcerative Colitis. Register Today!
Immunogenicity and safety study of 1 and 2 doses of GSK Biologicals’ meningococcal vaccine GSK134612 in toddlers, persistence up to 5 years after vaccination and co-administration with Pfizer’s pneumococcal vaccine Prevenar 13™. https://clinicaltrials.gov/ct2/show/NCT01939158?term=C0921003&rank=1 Register Today!
A Phase 3 Study to Evaluate the Efficacy, Safety, and Effect of Withdrawal and Retreatment With Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-1. Register Today!
A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-2. Register Today!
A phase III randomised, double-blind, active-controlled parallel group efficacy and safety study of BI 10773 compared to glimepiride administered orally during 104 weeks in patients with type 2 diabetes mellitus and insufficient glycaemic control despite metformin treatment. Register Today!
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study Of The Effects Of JNJ-28431754 On Cardiovascular Outcomes In Adult Subjects With Type 2 Diabetes Mellitus. Register Today!
About Lauri Lauri began with Medicor in 2005 while finishing her Bachelor degree at Laurentian University. She had many roles at Medicor and saw many changes over the years as the company grew and matured. Her talent for negotiating surfaced early on when given the task of helping to finalize overdue contracts and budgets, she…
About Marija Upon completion of her Bachelor of Life Sciences degree at Queen’s University in 2004, Marija went on to complete her Masters of Chemical Sciences degree in 2007. Marija then enjoyed a one year contract as a research assistant at Laurentian University working in the field of skeletal muscle plakins. Shifting her research focus…
About Barb Barb wears many hats at Medicor. She began her career in clinical research in 1996 and she says she got serious about clinical trials in 2005 when she incorporated Medicor. She has a background in both nursing and business and brings the two together to lead the company. She is passionate about helping…
